Jerry L. Robben
Optometrists (Optometrist)
- Medicare participating
At a glance
- Years since graduation
- 17
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 399
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Optometrist primary
FL license OPC4572
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Eye Associates of Manatee, LLP (61 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 399
- Services billed
- 2,328
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 764 | 316 |
| Microfluid analysis of tears | 535 | 185 |
| Analysis of substance using immunoassay technique, multiple step method | 234 | 106 |
| Exam of visual field with extended testing | 162 | 115 |
| Photography of the retina | 118 | 109 |
| Extended exam of the back part of the eye with optic nerve drawing | 104 | 102 |
| Exam of the internal drainage system of eye | 96 | 92 |
| Imaging of optic nerve | 86 | 86 |
| New patient office or other outpatient visit, 45-59 minutes | 64 | 64 |
| Fitting of contact lens for treatment of eye surface disease | 54 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Restasis (cyclosporine) Other prescribers in St Augustine, FL | 89 |
| Lumigan (bimatoprost) Other prescribers in St Augustine, FL | 85 |
| Latanoprost Other prescribers in St Augustine, FL | 65 |
| Prednisolone Acetate Other prescribers in St Augustine, FL | 50 |
| Dorzolamide Hcl Other prescribers in St Augustine, FL | 44 |
| Miebo (perfluorohexyloctane/pf) | 41 |
| Brimonidine Tartrate Other prescribers in St Augustine, FL | 33 |
| Loteprednol Etabonate | 31 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in St Augustine, FL | 27 |
| Tobramycin-Dexamethasone (tobramycin/dexamethasone) Other prescribers in St Augustine, FL | 26 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 82 payments worth $26,151 in total to this clinician.
| Bausch & Lomb Americas Inc. | $18,839 |
|---|---|
| AbbVie Inc. | $4,928 |
| Tarsus Pharmaceuticals, Inc. | $1,159 |
| Alcon Vision LLC | $257 |
| Oyster Point Pharma, Inc. | $204 |
| Sun Pharmaceutical Industries Inc. | $197 |
| Harrow Eye, LLC | $168 |
| Biotissue Holdings Inc. | $126 |
| Speaking at a medical education program | $17,125 |
|---|---|
| Consulting Fee | $5,200 |
| Food and Beverage | $2,802 |
| Travel and Lodging | $1,024 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. May 28, 2025 | Speaking at a medical education program MIEBO · Ophthalmology | $4,000 |
| Bausch & Lomb Americas Inc. Mar 12, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $4,000 |
| Bausch & Lomb Americas Inc. Jun 23, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $4,000 |
| Bausch & Lomb Americas Inc. Sep 2, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $4,000 |
| AbbVie Inc. Feb 28, 2025 | Consulting Fee DURYSTA · EYE CARE | $2,763 |
| AbbVie Inc. Feb 28, 2025 | Consulting Fee DURYSTA · EYE CARE | $1,063 |
| Tarsus Pharmaceuticals, Inc. Oct 1, 2025 | Consulting Fee | $950 |
| Bausch & Lomb Americas Inc. Oct 22, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $625 |
| Bausch & Lomb Americas Inc. May 28, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $500 |
| AbbVie Inc. Oct 8, 2025 | Consulting Fee | $425 |
All 15 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. Oct 22, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $625 |
| AbbVie Inc. Oct 8, 2025 | Consulting Fee | $425 |
| Tarsus Pharmaceuticals, Inc. Oct 1, 2025 | Consulting Fee | $950 |
| Bausch & Lomb Americas Inc. Sep 2, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $4,000 |
| Bausch & Lomb Americas Inc. Aug 21, 2025 | Travel and Lodging MIEBO; XIIDRA · Ophthalmology · travel to WINTER PARK, FL | $182 |
| Bausch & Lomb Americas Inc. Jun 23, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $4,000 |
| Bausch & Lomb Americas Inc. Jun 7, 2025 | Travel and Lodging MIEBO; XIIDRA · Ophthalmology · travel to LAKE BUENA VISTA, FL | $209 |
| Bausch & Lomb Americas Inc. May 28, 2025 | Speaking at a medical education program MIEBO · Ophthalmology | $4,000 |
| Bausch & Lomb Americas Inc. May 28, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $500 |
| Bausch & Lomb Americas Inc. May 1, 2025 | Travel and Lodging MIEBO · Ophthalmology · travel to WINTER PARK, FL | $164 |
| Bausch & Lomb Americas Inc. Mar 12, 2025 | Speaking at a medical education program MIEBO; XIIDRA · Ophthalmology | $4,000 |
| AbbVie Inc. Feb 28, 2025 | Consulting Fee DURYSTA · EYE CARE | $2,763 |
| AbbVie Inc. Feb 28, 2025 | Consulting Fee DURYSTA · EYE CARE | $1,063 |
| Bausch & Lomb Americas Inc. Feb 20, 2025 | Travel and Lodging MIEBO; XIIDRA · Ophthalmology · travel to WINTER PARK, FL | $172 |
| AbbVie Inc. Feb 11, 2025 | Travel and Lodging travel to LAKE BUENA VISTA, FL · in-kind | $297 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $7,180 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of DFL24498 HCl Eye Drop Solution Versus Vehicle in Adult Participants with Atopic Keratoconj…
Dompe Farmaceutici S.p.a. - OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
Oyster Point Pharma, Inc. · Recruiting · NCT07140783 - Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances
Oyster Point Pharma, Inc. · Completed · NCT06349759
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.